The digital transformation of pathology is opening up new possibilities for cancer diagnosis. Today's artificial intelligence ...

PathAI makes AI models that help with the analysis of patient tissue samples and diagnostic tools. Roche has partnered with ...

ArteraAI Breast is designed to stratify breast cancer patients into high- and low-risk groups to guide treatment decisions.

QIMR Berghofer scientists have developed an AI screening tool that harnesses the power of cutting-edge spatial biology ...

PathAI, a global leader in AI-powered digital pathology solutions, and A.C.Camargo Cancer Center, a national benchmark in oncological treatment, education, and research, are joining forces ...

Dicom Systems, a leader in enterprise imaging workflow orchestration and interoperability, announced today that it will partner with Moffitt Cancer Center to support and scale its digital pathology ...

In a recent study published in the journal Nature, researchers developed and evaluated the Providence Gigapixel Pathology Model (Prov-GigaPath), a whole-slide pathology foundation model, to achieve ...

Researchers at University Hospital Cologne have developed SPARK, an agent-based AI framework that autonomously generates and refines biological hypotheses in cancer pathology. The system integrates ...

The FDA has cleared ArteraAI Breast, the first digital pathology-based risk stratification tool for breast cancer. The AI software analyzes tumor tissue images and clinical data to categorize ...

A study warns that millions of people with cancer could die undiagnosed due to failures in healthcare systems.

The chief of clinical pathology at the largest hospital in St. John's told a courtroom Thursday that he did not consider a probe into a controversial laboratory a peer review. That is counter to the ...

The Department of Pathology, Hospital Escuela Oscar Danilo Rosales Argüello (HEODRA), León, Nicaragua, decided to introduce and implement synoptic reporting for all cancer cases beginning in 2018. All ...